China’s War on Drugs

The National Narcotics Control Commission in China have reported that by the end of 2016, there was an estimated 2.5 million drugs users in the country. 1.5 million of which are described to have been using new synthetic drugs as oppose to the traditional drugs seen in the past. In the same year, 445,000 Chinese residents started using drugs, of which 81% are reported to have been a classified substance according to the Sixth Tone.

Further studies confirmed that in China traditional drug user profiles have changed, revealing that 30 – 34 year olds were 4.3 times more likely to consume drugs. Discussing the matter professor Pan Suiming states, “Recreational drugs play a decreased social role among Chinese college students. But by the age of 25, people are more likely to have friends who have access to drugs.” Social pressure has been named as a key explanation into the increasingly scary statistics.

KCBA reported the Chinese drug policy revealing that, “Since 1991 drug offenses have been met with mass executions and a policy of widespread governmental secrecy. During this time, drug use has only been shown to increase.” It is predicted that despite China’s extreme punishments, the country’s drug problem will only continue to grow at a rapid rate.

Randox Toxicology’s revolutionary Biochip Array Technology is designed to work across a wide variety of matrices, boasting cutting edge multiplex testing capabilities that provide rapid and accurate drug detection from a single sample. Our drugs of abuse Biochip arrays form part of our unrivalled toxicology test menu capable of detecting over 500 drugs. As the number one supplier of New Psychoactive Substances including Synthetic Cannabinoids, Randox Toxicology can provide the answer to testing for both classic designer drugs and designer fentanyl and opioid substances.

NPS I: Classic Designer Drugs
NPS II: Designer Fentanyl & Opioids
For more information about our revolutionary Biochip Array Technology or New Psychoactive Substances panels, email or visit

Request Demo